Mr. Geoff Benic reports

SAFE SUPPLY SECURES EXCLUSIVE CANADIAN RIGHTS TO HEALTHY SPRAYS' PROPRIETARY GLP-1 DELIVERY TECHNOLOGY; ANNOUNCES NON-BROKERED PRIVATE PLACEMENT

Safe Supply Streaming Co Ltd. has entered into an exclusive territory licence and commercial agreement with Healthy Sprays LLC, granting Safe Supply the exclusive Canadian rights to distribute the full Healthy Sprays portfolio of innovative GLP-1 solutions.

Healthy Sprays is a United States-based leader in non-injectable metabolic health solutions. Its product line, featuring Thin (3.0-milligram GLP-1spray), Thin-R (7.2 mg GLP-1 spray) and THIN-ST (5.0 mg tirzepatide spray), includes a proprietary sublingual spray delivery technology designed to enhance the overall user experience. The technology includes a refrigeration-free solution designed for rapid impact.

"This partnership represents a major step in bringing modern, consumer-ready health care solutions to Canadians," said Geoff Benic, chief executive officer of Safe Supply. "Needle-free GLP-1 therapies offer an alternative for consumers seeking convenience and accessibility without injections."

"We are pleased to expand our technology into the Canadian market," said Logan Doughty, chief executive officer of Healthy Sprays. "Safe Supply's health-care-focused distribution network and operational discipline make them the ideal partner to scale our innovative GLP-1 platform across the country."

A multiyear pathway to transforming GLP-1 delivery in Canada

Under the terms of the Licensing agreement, which begins in January, 2026, and spans an initial five-year period, with extension provisions, Safe Supply obtains:

• Exclusive nationwide distribution rights for all Healthy Sprays products;
• Access to Healthy Sprays' proprietary business model, operating systems and product IP;
• Rights to future Healthy Sprays formulations.

A meaningful advancement in consumer accessibility

"Providing Canadians with a safe, modern alternative to injectable therapies will help Safe Supply expand access to metabolic health solutions for those who need them most," said Raf Souccar, chairman of the Safe Supply board of directors and former deputy commissioner of the RCMP.

Given evolving market dynamics heading into 2026, innovative GLP-1 therapies such as Thin represent an important development anticipated for the category. With the exclusivity granted under the licensing agreement, Safe Supply is well positioned to establish a market-leading role as alternative GLP-1 solutions move toward mainstream adoption in Canada.

Under the terms of the licensing agreement, Safe Supply will pay Healthy Sprays a one-time, non-refundable upfront licence fee of $250,000 (U.S.), payable in tranches. In addition, Safe Supply will remit a royalty on Canadian gross sales, and will purchase all product packaging and delivery technology directly from Healthy Sprays at a fixed cost. The licensing agreement also establishes minimum net sales requirements for each contract year.

Private placement offering

The company is also pleased to announce a proposed non-brokered private placement of units at a price of five cents per unit for gross proceeds of up to $500,000. Each unit consists of one common share and one-half of one common share purchase warrant, with each warrant exercisable for one share at a price of 7.5 cents per share for two years from closing.

The net proceeds from the offering will be used to finance the licensing fee, certain other expenses relating to activities under the licensing agreement, and general corporate and working capital purposes.

In connection with the offering, the company may pay finders' fees of up to 7 per cent cash and 7 per cent broker's warrants exercisable for the purchase of one unit at a price of five cents for a period of two years to eligible finders in connection with the offering, subject to compliance with applicable securities laws and policies of the Canadian Securities Exchange.

Closing of the offering is subject to the company obtaining all necessary corporate and regulatory approvals, including approval from the Canadian Securities Exchange. All securities issued in connection with the offering will be subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation in Canada.

About Healthy Sprays LLC

Healthy Sprays is a United States-based health care innovator developing innovative GLP-1 solutions using a proprietary sublingual spray platform. Built with Food and Drug Administration-approved components and USP-compliant materials, the Healthy Sprays product line includes Thin, Thin-R, Thin-ST and additional formulations under development.

About Safe Supply Streaming Co. Ltd.

Safe Supply Streaming is a publicly-traded company focused on advancing innovation in health care, wellness and emerging technologies. Through strategic acquisitions, partnerships and capital investments, Safe Supply is building a diversified portfolio of companies that leverage data, science and digital platforms to improve outcomes, drive accessibility and scale impact. Operating at the intersection of public health and technology, Safe Supply supports evidence-informed solutions to urgent societal needs. Its wholly owned subsidiaries, including Safety Strips Tech Corp. and Drug Lab 118 Ltd., develop proprietary rapid testing technologies such as fentanyl and drink-spiking detection products which are designed to enhance health outcomes and enhance public safety and wellness.

We seek Safe Harbor.